Scott D Solomon

2.1k total citations · 3 hit papers
36 papers, 852 citations indexed

About

Scott D Solomon is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Scott D Solomon has authored 36 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 12 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Nephrology. Recurrent topics in Scott D Solomon's work include Heart Failure Treatment and Management (18 papers), Cardiovascular Function and Risk Factors (17 papers) and Diabetes Treatment and Management (7 papers). Scott D Solomon is often cited by papers focused on Heart Failure Treatment and Management (18 papers), Cardiovascular Function and Risk Factors (17 papers) and Diabetes Treatment and Management (7 papers). Scott D Solomon collaborates with scholars based in United States, United Kingdom and France. Scott D Solomon's co-authors include John J.V. McMurray, Pardeep S. Jhund, Milton Packer, Brian Claggett, Faı̈ez Zannad, João Pedro Ferreira, Muthiah Vaduganathan, Jonathan W. Cunningham, Gregg C. Fonarow and Akshay S. Desai and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Scott D Solomon

23 papers receiving 833 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

2020 362 citations Muthiah Vaduganathan, Brian Claggett et al. The Lancet profile →
Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis

2024 52 citations Pardeep S. Jhund, Atefeh Talebi et al. The Lancet profile →
Heart failure with preserved ejection fraction

2024 38 citations Sanjiv J. Shah, Scott D Solomon et al. profile →

Peers

Countries citing papers authored by Scott D Solomon

Since Specialization

Citations

This map shows the geographic impact of Scott D Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott D Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott D Solomon more than expected).

Fields of papers citing papers by Scott D Solomon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott D Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott D Solomon. The network helps show where Scott D Solomon may publish in the future.

Co-authorship network of co-authors of Scott D Solomon

This figure shows the co-authorship network connecting the top 25 collaborators of Scott D Solomon. A scholar is included among the top collaborators of Scott D Solomon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott D Solomon. Scott D Solomon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical Trials 2025 ·Journal of the American College of Cardiology ·(unknown), (unknown), Brian Claggett, (unknown), Mahnaz Maddah, Shaan Khurshid, Orly Vardeny, Eldrin F. Lewis, Pardeep S. Jhund, Akshay S. Desai, Patrick T. Ellinor, Jennifer E. Ho, John J.V. McMurray, Marc A. Pfeffer, Scott D Solomon, Jonathan W. Cunningham	0
2	Finerenone and NYHA Functional Class in Heart Failure 2025 ·JACC Heart Failure ·John W. Ostrominski, Muthiah Vaduganathan, Brian Claggett, Akshay S. Desai, Pardeep S. Jhund, (unknown), Michele Senni, (unknown), Adriaan A. Voors, Faı̈ez Zannad, Bertram Pitt, (unknown), Katja Rohwedder, James Lay‐Flurrie, (unknown), John J.V. McMurray, Scott D Solomon	0
3	Worsening of Heart Failure in Outpatients With Transthyretin Amyloidosis and Cardiomyopathy in the APOLLO-B Trial 2025 ·Journal of the American College of Cardiology ·(unknown), Matthew J. Maurer, Julian D. Gillmore, Shaun Bender, Patrick Y. Jay, Scott D Solomon	1
4	Finerenone Across the Spectrum of Kidney Risk in Heart Failure 2025 ·JACC Heart Failure ·John W. Ostrominski, Finnian R. Mc Causland, Brian Claggett, Akshay S. Desai, Pardeep S. Jhund, (unknown), Michele Senni, (unknown), Adriaan A. Voors, Faı̈ez Zannad, Bertram Pitt, Patrick Schloemer, Meike Brinker, Markus F. Scheerer, John J.V. McMurray, Scott D Solomon, Muthiah Vaduganathan	3
5	Finerenone, Glycaemic Status, and Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial 2025 ·European Journal of Heart Failure ·Jawad H. Butt, Pardeep S. Jhund, Alasdair Henderson, Brian Claggett, Akshay S. Desai, (unknown), Meike Brinker, Patrick Schloemer, Prabhakar Viswanathan, Andrea Lage, Katja Rohwedder, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D Solomon, John J.V. McMurray	0
6	Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD 2025 ·Kidney International Reports ·Bernard Chan, (unknown), Sunil V. Badve, Roberto Pecoits‐Filho, Murilo Guedes, Clare Arnott, Rebecca Kozor, Emma O’Lone, Min Jun, Sradha Kotwal, Geoffrey A. Block, Glenn M. Chertow, Scott D Solomon, Muthiah Vaduganathan, Vlado Perkovic, Brendon L. Neuen	2
7	Effects of Vutrisiran on Cardiac Function and Outcomes in Patients With Transthyretin Amyloidosis With Cardiomyopathy 2025 ·Journal of the American College of Cardiology ·Karola Jering, (unknown), Hicham Skali, Bernard E. Bulwer, Narayana Prasad, Farideh Roshanali, Olivier Lairez, Simone Longhi, Olga Azevedo, Shaun Bender, Patrick Y. Jay, Joshua R. Vest, Scott D Solomon	0
8	Digital Nudges to Increase Influenza Vaccination in Patients with Chronic Diseases 2025 ·NEJM Evidence ·Niklas Dyrby Johansen, (unknown), Ankeet S. Bhatt, Daniel Modin, Brian Claggett, Kira Hyldekær Janstrup, Carsten Schade Larsen, Lykke Larsen, Lothar Wiese, (unknown), Lars Køber, Scott D Solomon, Pradeesh Sivapalan, Jens‐Ulrik Stæhr Jensen, Cyril Jean‐Marie Martel, Tyra Grove Krause, Tor Biering‐Sørensen	0
9	Myocardial contraction fraction predicts outcomes in patients enrolled in the TOPCAT trial 2025 ·International Journal of Cardiology ·(unknown), (unknown), (unknown), Miriam Elman, (unknown), Amil M. Shah, Mathew S. Maurer, Scott D Solomon, Ahmad Masri	0
10	Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction 2025 ·Journal of the American College of Cardiology ·John W. Ostrominski, Brendon L. Neuen, Brian Claggett, Inder S. Anand, Akshay S. Desai, Pardeep S. Jhund, Carolyn S.P. Lam, Marc A. Pfeffer, B. Pitt, Faı̈ez Zannad, Michael R. Zile, Milton Packer, Kieran F. Docherty, John J.V. McMurray, Scott D Solomon, Muthiah Vaduganathan	0
11	Blinded Withdrawal of Finerenone After Long-Term Treatment in the FINEARTS-HF Trial 2025 ·Journal of the American College of Cardiology ·(unknown), Brian Claggett, Jacob A. Udell, Akshay S. Desai, Pardeep S. Jhund, Alasdair Henderson, James Lay‐Flurrie, Flaviana Amarante, Andrea Glasauer, (unknown), Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Bertram Pitt, John J.V. McMurray, Scott D Solomon	1
12	Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection Fraction 2025 ·Journal of the American College of Cardiology ·Kyung Hoon Min, Alan S. Go, (unknown), Rishi Parikh, (unknown), Andrew P. Ambrosy, Thida C. Tan, (unknown), (unknown), (unknown), Scott D Solomon, Riccardo M. Inciardi, Orly Vardeny, (unknown), Alexander T. Sandhu, (unknown), (unknown), Ankeet S. Bhatt	2
13	Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis breakdown → 2024 ·The Lancet ·Pardeep S. Jhund, Atefeh Talebi, Alasdair Henderson, Brian Claggett, Muthiah Vaduganathan, Akshay S. Desai, Carolyn S.P. Lam, Bertram Pitt, Michele Senni, Sanjiv J Shah, Adriaan A. Voors, Faı̈ez Zannad, Scott D Solomon, John J.V. McMurray	52
14	Why Has it Been Challenging to Modify Kidney Disease Progression in Patients With Heart Failure? 2024 ·Journal of the American College of Cardiology ·Muthiah Vaduganathan, Brendon L. Neuen, Finnian R. McCausland, Pardeep S. Jhund, Kieran F. Docherty, John J.V. McMurray, Scott D Solomon	5
15	Excess Mortality and Hospitalizations Associated With Seasonal Influenza in Patients With Heart Failure 2024 ·Journal of the American College of Cardiology ·Daniel Modin, Brian Claggett, Niklas Dyrby Johansen, Scott D Solomon, Ramona Trebbien, (unknown), Jens‐Ulrik Stæhr Jensen, Mikkel Porsborg Andersen, (unknown), Tor Biering‐Sørensen	3
16	Acute Changes in Kidney Function and Outcomes Following an Acute Myocardial Infarction: Insights from PARADISE-MI 2024 ·European Journal of Heart Failure ·Finnian R. Mc Causland, Martina M. McGrath, Brian Claggett, Ebrahim Barkoudah, Cara East, Alberto Fernández, Karola Jering, Eldrin F. Lewis, John J.V. McMurray, Freny Vaghaiwalla Mody, Scott D Solomon, Mariya Tokmakova, Peter van der Meer, Yinong Zhou, Marc A. Pfeffer	0
17	Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials breakdown → 2020 ·The Lancet ·Muthiah Vaduganathan, Brian Claggett, Pardeep S. Jhund, Jonathan W. Cunningham, João Pedro Ferreira, Faı̈ez Zannad, Milton Packer, Gregg C. Fonarow, John J.V. McMurray, Scott D Solomon	362
18	Use of the Win Ratio in Cardiovascular Trials 2020 ·JACC Heart Failure ·João Pedro Ferreira, Pardeep S. Jhund, Kévin Duarte, Brian Claggett, Scott D Solomon, Stuart Pocock, Mark C Petrie, Faı̈ez Zannad, John J.V. McMurray	50
19	DIFFERENCES IN LONGITUDINAL MYOCARDIAL FUNCTION BETWEEN THE THREE MAIN TYPES OF CARDIAC AMYLOIDOSIS: AN INSIGHT INTO DIFFERENT MECHANISMS OF SURVIVAL? 2013 ·Journal of the American College of Cardiology ·Candida Cristina Quarta, Imran Uraizee, Rodney H. Falk, Jenna Kruger, Simone Longhi, Claudio Rapezzi, Scott D Solomon	1
20	Predictors of sudden cardiac death change with time after myocardial infarction: Results from the VALIANT Trial 2008 ·Journal of the American College of Cardiology ·Jonathan P. Piccini, Karen S. Pieper, Scott D Solomon, Sana M. Al‐Khatib, Frans Van de Werf, Marc A. Pfeffer, John J.V. McMurray, Robert M. Califf, Eric J. Velazquez	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact